SecBot SecBot
SECBOTREPLAY Home › Report › REPL

REPL · Replimune Group priced a $150M underwritten offering of 9.7M common…

Replimune Group, Inc. · 8-K filed Aug 10, 2026 at 07:50 ET

At the news

BEARISHIMPACT 6/10

8-K filed Aug 10, 2026 at 07:50 ET

Replimune Group priced a $150M underwritten offering of 9.7M common shares at $12.06/share and 2.7M pre-funded warrants at $12.0599/warrant. Estimated net proceeds are approximately $140.5M. The dilutive offering more than doubles the company's cash balance but adds ~18% share overhang, typical for a commercial-stage biotech funding pipeline and commercialization.

  • Offering of 9,701,490 common shares + 2,736,340 pre-funded warrants (exercise price $0.0001)
  • Aggregate gross proceeds of approximately $150M; estimated net proceeds ~$140.5M
  • Offering priced at $12.06 per share, a ~13% discount to the $12.40 opening on Aug 7 pre-filing
  • Underwriters: Leerink Partners, J.P. Morgan, Cantor Fitzgerald

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access